Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Related Citations for PubMed (Select 24626943)

1.

Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.

Maciel GA, Moreira RP, Bugano DD, Hayashida SA, Marcondes JA, Gomes LG, Mendonça BB, Bachega TA, Baracat EC.

Clinics (Sao Paulo). 2014 Mar;69(3):179-84. doi: 10.6061/clinics/2014(03)06.

2.

Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency.

Moreira RP, Gomes LG, Mendonca BB, Bachega TA.

PLoS One. 2012;7(9):e44893. doi: 10.1371/journal.pone.0044893. Epub 2012 Sep 18.

3.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055. Epub 2014 Jan 2.

PMID:
24388959
4.

The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.

Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podestà F, Koper JW, Liuzzi A, Lamberts SW.

Clin Endocrinol (Oxf). 2003 Jul;59(1):68-74.

PMID:
12807506
5.

[Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].

Ságodi L, Lombay B, Vámosi I, Barkai L.

Orv Hetil. 2013 Aug 4;154(31):1226-34. doi: 10.1556/OH.2013.29669. Hungarian.

PMID:
23895991
6.

Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease.

Moreira RP, Bachega TA, Machado MC, Mendonca BB, Bronstein MD, Villares Fragoso MC.

Clinics (Sao Paulo). 2013 May;68(5):579-85. doi: 10.6061/clinics/2013(05)01.

7.

BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.

Giordano R, Marzotti S, Berardelli R, Karamouzis I, Brozzetti A, D'Angelo V, Mengozzi G, Mandrile G, Giachino D, Migliaretti G, Bini V, Falorni A, Ghigo E, Arvat E.

Clin Endocrinol (Oxf). 2012 Dec;77(6):863-70. doi: 10.1111/j.1365-2265.2012.04439.x.

PMID:
22587831
8.

Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.

Skrgatić L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Corić M.

Coll Antropol. 2013 Mar;37(1):141-6.

PMID:
23697264
9.

Impact of angiotensin II type 1 receptor gene polymorphism on insulin resistance in polycystic ovary syndrome.

El-Mesallamy H, El-Refaie T, El-Razek RA.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):188-93. doi: 10.1055/s-0032-1333234. Epub 2013 Apr 5.

PMID:
23564192
10.

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.

Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T.

Metabolism. 2008 Dec;57(12):1765-71. doi: 10.1016/j.metabol.2008.08.002.

PMID:
19013303
11.

[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].

Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E.

Endocrinol Nutr. 2009 Feb;56(2):59-65. doi: 10.1016/S1575-0922(09)70553-4. Epub 2009 May 1. Spanish.

PMID:
19627713
12.

Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.

Valkenburg O, Uitterlinden AG, Themmen AP, de Jong FH, Hofman A, Fauser BC, Laven JS.

Hum Reprod. 2011 Oct;26(10):2902-11. doi: 10.1093/humrep/der222. Epub 2011 Jul 28.

13.

Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

Tan S, Scherag A, Janssen OE, Hahn S, Lahner H, Dietz T, Scherag S, Grallert H, Vogel CI, Kimmig R, Illig T, Mann K, Hebebrand J, Hinney A.

BMC Med Genet. 2010 Jan 21;11:12. doi: 10.1186/1471-2350-11-12.

14.

Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in southwest Chinese women with polycystic ovary syndrome.

Liu HW, Zhang F, Fan P, Bai H, Zhang JX, Wang Y.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):146-51. doi: 10.1016/j.ejogrb.2013.04.016. Epub 2013 Jun 6.

PMID:
23746632
15.

Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome.

Trementino L, Appolloni G, Concettoni C, Cardinaletti M, Boscaro M, Arnaldi G.

Eur J Endocrinol. 2012 Jan;166(1):35-42. doi: 10.1530/EJE-11-0722. Epub 2011 Nov 2.

16.
17.

The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.

Dravecká I, Lazúrová I, Habalová V.

Gynecol Endocrinol. 2010 May;26(5):356-60. doi: 10.3109/09513590903511497.

PMID:
20170352
18.
19.

Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome.

Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou GP, Papassotiriou I, Tsatsoulis A.

Clin Chem. 2005 Feb;51(2):416-23. Epub 2004 Dec 8.

20.

Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.

Schweighofer N, Lerchbaum E, Trummer O, Schwetz V, Pilz S, Pieber TR, Obermayer-Pietsch B.

Gene. 2012 Aug 1;504(1):133-9. doi: 10.1016/j.gene.2012.04.050. Epub 2012 Apr 28.

PMID:
22565190
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk